Thyroid autoantibodies are associated with a reduced prevalence of frailty in community-dwelling older women
- PMID:20061418
- PMCID: PMC2841533
- DOI: 10.1210/jc.2009-1991
Thyroid autoantibodies are associated with a reduced prevalence of frailty in community-dwelling older women
Abstract
Context: The contribution of autoimmunity to the multisystem dysregulation that characterizes the frailty syndrome in older adults is unknown.
Objective: The aim of the study was to investigate the relationship between thyroid antibodies and frailty in older women.
Design, setting, and participants: We conducted a cross-sectional study nested within the Women's Health and Aging Studies I and II. Thyroglobulin antibodies (TgAbs), thyroid peroxidase antibodies (TPOAbs), and antinuclear antibodies were measured in the baseline sera of 641 community-dwelling older women.
Main outcome measure: Frailty was defined using a validated five-component measure.
Results: The prevalence of prefrailty and frailty was lower in TgAb-positive than negative older women (37.1 vs. 47.8% and 6.7 vs.11.9%, respectively; P = 0.01 and 0.03). The prevalence of prefrailty, but not frailty, was lower in TPOAb-positive than negative women (38.9 vs. 48.0% and 10.1 vs. 11.3%; P = 0.04 and 0.34). After adjustment for covariates including serum thyroid stimulation hormone concentration and thyroid medication usage in multinomial regression models, TgAb-positive older women had lower odds of prefrailty and frailty compared with TgAb-negative women (odds ratio 0.57 and 0.30; 95% confidence interval 0.34-0.98 and 0.10-0.85, respectively). Similarly, TPOAb-positive older women had lower odds of frailty compared with TPOAb-negative women (odds ratio 0.44; 95% confidence interval 0.20-0.96). These trends were not observed with antinuclear antibodies.
Conclusion: Independent of thyroid function status, community-dwelling older women who are seropositive for TgAbs and TPOAbs are less likely to be frail than seronegative women.
Figures

References
- Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, Cardiovascular Health Study Collaborative Research G 2001 Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156 - PubMed
- Bandeen-Roche K, Xue QL, Ferrucci L, Walston J, Guralnik JM, Chaves P, Zeger SL, Fried LP 2006 Phenotype of frailty: characterization in the women’s health and aging studies. J Gerontol A Biol Sci Med Sci 61:262–266 - PubMed
- Ensrud KE, Ewing SK, Taylor BC, Fink HA, Cawthon PM, Stone KL, Hillier TA, Cauley JA, Hochberg MC, Rodondi N, Tracy JK, Cummings SR 2008 Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 168:382–389 - PubMed
- Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, Masaki K, Murray A, Newman AB, Women’s Health I 2005 Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc 53:1321–1330 - PubMed
- Lipsitz LA 2004 Physiological complexity, aging, and the path to frailty. Sci Aging Knowledge Environ 2004:pe16 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- KL2-RR025006/RR/NCRR NIH HHS/United States
- R37 AG019905/AG/NIA NIH HHS/United States
- P30 AG021334/AG/NIA NIH HHS/United States
- KL2 RR025006/RR/NCRR NIH HHS/United States
- R37-AG19905/AG/NIA NIH HHS/United States
- R01-A141956/PHS HHS/United States
- R01-DK55670/DK/NIDDK NIH HHS/United States
- R01 DK055670/DK/NIDDK NIH HHS/United States
- R01 AG011703/AG/NIA NIH HHS/United States
- P30-AG021334/AG/NIA NIH HHS/United States
- N01-AG-1-2112/AG/NIA NIH HHS/United States
- R01-AG11703/AG/NIA NIH HHS/United States
- M01 RR000722/RR/NCRR NIH HHS/United States
